The use of surfactants in 2009

Archives of Disease in Childhood: Education and Practice Edition

Volumn 94, Issue 3, 2009, Pages 78-83

  Sweet, D G ^a   Halliday, Henry L ^b  

^a ROYAL MATERNITY HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BERACTANT; BRONCHODILATING AGENT; BUDESONIDE; CALFACTANT; DIPALMITOYLPHOSPHATIDYLCHOLINE; PORACTANT; PUMACTANT; STEROID; SURFACTANT;

ABSENCE OF SIDE EFFECTS; ARTIFICIAL VENTILATION; CLINICAL TRIAL; DIAPHRAGM HERNIA; DRUG COST; DRUG DELIVERY SYSTEM; DRUG INDICATION; DRUG SYNTHESIS; EARLY INTERVENTION; ENDOBRONCHIAL INTUBATION; EVIDENCE BASED MEDICINE; HUMAN; LUNG DYSPLASIA; LUNG HEMORRHAGE; MECONIUM ASPIRATION; NONHUMAN; PNEUMONIA; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPEATED DRUG DOSE; RESPIRATORY DISTRESS SYNDROME; REVIEW; SINGLE DRUG DOSE; STEROID THERAPY; SURVIVAL RATE; THERAPY EFFECT;

HUMANS; INFANT, NEWBORN; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 67749122344     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2008.153023     Document Type: Review

References (52)

1. Fujiwara T, Maeta H, Chida S, et al. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980 12;1:55-59 (Pubitemid 10199398)
2. Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000;(2):CD000511.
3. Soll RF. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000;(2):CD001079.
4. Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2000;(2):CD001149.
5. BAPM RDS/Surfactant Guidelines Group. Guidelines for good practice in the management of respiratory distress syndrome. Available from http://www.bapm.org/media/documents/publications/rds.pdf (accessed 8 April 2009).
6. Engle WA, American Academy of Pediatrics Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008;121:419-432
7. Fetus and Newborn Committee, Canadian Paediatric Society (CPS). Recommendations for neonatal surfactant therapy. J Paediatr Child Health 2005;10:109-116
8. Sweet D, Bevilacqua G, Carnielli V, et al. European Consensus Guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med 2007;35:175-186 (Pubitemid 46700981)
9. Ho JJ, Subramaniam P, Henderson-Smart DJ, et al. Continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002;(2):CD002271.
10. De Klerk AM, De Klerk RK. Nasal continuous positive airway pressure and outcomes of preterm infants. J Paediatr Child Health 2001;37:161-167 (Pubitemid 32398097)
11. Aly H, Milner JD, Patel K, et al. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics 2004;114:697-702. (Pubitemid 41529526)
12. Marshall DD, Kotelchuck M, Young TE, et al. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 1999;104:1345-1350
13. Egberts J, Brand R, Walti H, et al. Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. Pediatrics 1997;100:e4.
14. Björklund LJ, Ingimarsson J, Curstedt T, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997;42:348-355 (Pubitemid 27362732)
15. Davis JW, Sweet DG. Pathophysiology and prevention of bronchopulmonary dysplasia. Curr Paediatr Rev 2008;4:2-14.
16. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999;103:E24.
17. Fernández-Ruanova MB, Alvarez FJ, Gastiasoro E, et al. Comparison of rapid bolus instillation with simplified slow administration of surfactant in lung lavaged rats. Pediatr Pulmonol 1998;26:129-134 (Pubitemid 28381476)
18. Dijk PH, Heikamp A, Piers DA, et al. Surfactant nebulization: safety, efficiency and influence on surface lowering properties and biochemical composition. Intensive Care Med 1997;23:456-462 (Pubitemid 27196979)
19. Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000;(2):CD001456.
20. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001;(2):CD000510.
21. Kendig JW, Ryan RM, Sinkin RA, et al. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. Pediatrics 1998;101:1006-1012
22. Kattwinkel J, Bloom BT, Delmore P, et al. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics 1993;92:90-98 (Pubitemid 23188874)
23. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001;(2):CD000144.
24. Whitsett JA, Hull WM, Luse S. Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with Survanta, a modified bovine surfactant. Pediatrics 1991;87:505-510
25. Robertson B, Curstedt T, Tubman TR, et al. A 2-year follow-up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group. Eur J Pediatr 1992;151:372-376
26. Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, et al. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics 2005;115:1030-1038
27. Moya F, Gadzinowski J, Bancalari E, et al. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome in very preterm infants. Pediatrics 2005;115:1018-1029
28. Kattwinkel J. Synthetic surfactants: the search goes on. Pediatrics 2005;115:1075-1076
29. Osborn DA, Jeffery HE, Bredemeyer SL, et al. Targeted early rescue surfactant in ventilated preterm infants using the click test. Pediatrics 2000;106:e30.
30. O'Donnell CP, Kamlin CO, Davis PG, et al. Endotracheal intubation attempts during neonatal resuscitation: success rates, duration, and adverse effects. Pediatrics 2006;117:e16-21.
31. Morley CJ, Davis PG, Doyle LW, et al, COIN Trial Investigators. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008;358:700-708
32. Rojas MA, Lozano JM, Rojas MX, et al. Colombian Neonatal Research Network. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009;123:137-142
33. Sandri F, Plavka R, Simeoni U, CURPAP Advisory Board. The CURPAP Study: an international randomized controlled trial to evaluate the efficacy of combining prophylactic surfactant and early nasal continuous positive pressure in very preterm infants. Neonatology 2008;94:60-62 (Pubitemid 351896596)
34. Soll RF. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst Rev 1999;(2):CD000141.
35. Kattwinkel J, Bloom BT, Delmore P, et al. High- versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome. Pediatrics 2000;106:282-288 (Pubitemid 30636396)
36. Ainsworth SB, Milligan DW. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review. Am J Respir Med 2002;1:417-433 (Pubitemid 37062709)
37. Halliday HL. History of surfactant from 1980. Biol Neonate 2005;87:317-322
38. Halliday HL. Recent clinical trials of surfactant treatment for neonates. Biol Neonate 2006;89:323-329 (Pubitemid 43886948)
39. Halliday HL. Surfactants: past, present and future. J Perinatol 2008;28:S47-S56.
40. Bloom BT, Clark RH, Infasurf Survanta Clinical Trial Group. Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome. Pediatrics 2005;116:392-399
41. Ramanathan R. Choosing a right surfactant for respiratory distress syndrome treatment. Neonatology 2009;95:1-5.
42. El Shahed AI, Dargaville P, Ohlsson A, et al. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev 2007;(3):CD002054. (Pubitemid 351805662)
43. Dargaville PA, Copnell B, Tingay DG, et al. Refining the method of therapeutic lung lavage in meconium aspiration syndrome. Neonatology 2008;94:160-163
44. Lotze A, Knight GR, Martin GR, et al. Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 1993;122:261-268 (Pubitemid 23041559)
45. Aziz A, Ohlsson A. Surfactant for pulmonary hemorrhage in neonates. Cochrane Database Syst Rev 2008;(2):CD005254.
46. Herting E, Gefeller O, Land M, et al. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group. Pediatrics 2000;106:957-964
47. Herting E, Möller O, Schiffmann JH, et al. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome. Acta Paediatr 2002;91:1174-1178 (Pubitemid 35347031)
48. Willson DF, Thomas NJ, Markovitz BP, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: a randomized controlled trial. JAMA 2005;293:470-476
49. Yeh TF, Lin HC, Chang CH, et al. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 2008;121:e1310-18.
50. Kribs A, Vierzig A, Hunseler C, et al. Early surfactant in spontaneously breathing with nCPAP in ELBW infants - a single center four year experience. Acta Paediatr 2008;97:293-298
51. Kattwinkel J, Robinson M, Bloom BT, et al. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol 2004;24:360-365 (Pubitemid 38931090)
52. Trevisanuto D, Grazzina N, Ferrasse P, et al. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate 2005;87:217-220 (Pubitemid 41094904)